Literature DB >> 32271996

Which serum uric acid levels are associated with increased cardiovascular risk in the general adult population?

Alena Krajčoviechová1, Peter Wohlfahrt1, Jan Bruthans1,2, Pavel Šulc1, Věra Lánská3, Lenka Eremiášová4, Jan Pudil4, Aleš Linhart4, Jan Filipovský2, Otto Mayer2, Jiří Widimský5, Milan Blaha6, Claudio Borghi7, Renata Cífková1,4.   

Abstract

Our aim was to determine the serum uric acid (SUA) levels associated with an increased risk of cardiovascular (CV) and all-cause death in the general adult population. We analyzed data obtained in two independent cross-sectional surveys performed in the Czech Republic in 2006-09 and 2015-18, involving 1% population random samples in nine districts, aged 25-64 years, stratified by age and gender. Ten-year mortality data were obtained in a cohort with examination in 2006-09. Final analyses included 3542 individuals (48.2% men) examined in 2006-09, and 2304 (47.4% men) examined in 2015-18. From a cohort examined in 2006-09, 122 men and 60 women were reported dead (33% and 27% from CV disease). In men, there was no association of baseline SUA levels with baseline SCORE category or 10-year mortality rates. In women, each 10 µmol/L increase in baseline SUA levels was associated with an increase in baseline SCORE category (P < .001). Receiver operating characteristic curve analyses in women identified the baseline SUA cutoff values discriminating: 1. between low/intermediate and high/very high SCORE categories (309 µmol/L), 2. CV mortality (325 µmol/L), and 3. all-cause mortality (298 µmol/L). After adjusting for confounders including SCORE, Cox regression analysis confirmed that the baseline SUA cutoffs of 309 µmol/L and 325 µmol/L were associated with 4-times (P = .010) and 6-times (P = .036) greater risk of CV mortality, whereas the cutoff of 298 µmol/L was associated with 87% greater risk of all-cause mortality (P = .025). In conclusion, the SUA cutoff value of 309 µmol/L identified women at high/very high SCORE category and was associated with 4-times greater risk of observed CV mortality over 10 years.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  SCORE; cardiovascular; gender differences; risk; uric acid

Mesh:

Substances:

Year:  2020        PMID: 32271996      PMCID: PMC8029678          DOI: 10.1111/jch.13847

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  35 in total

1.  Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA.

Authors:  Renata Cífková; Zdenka Skodová; Jan Bruthans; Vera Adámková; Marie Jozífová; Markéta Galovcová; Peter Wohlfahrt; Alena Krajcoviechová; Rudolf Poledne; Petr Stávek; Vera Lánská
Journal:  Atherosclerosis       Date:  2010-04-14       Impact factor: 5.162

2.  Serum uric acid levels positively correlates with 10-year cardiovascular risk score in the general population from China.

Authors:  Guo-Zhe Sun; Hao-Yu Wang; Yin-Tao Chen; Ying-Xian Sun
Journal:  Int J Cardiol       Date:  2018-09-01       Impact factor: 4.164

3.  Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study.

Authors:  B F Culleton; M G Larson; W B Kannel; D Levy
Journal:  Ann Intern Med       Date:  1999-07-06       Impact factor: 25.391

4.  Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study.

Authors:  P Verdecchia; G Schillaci; G Reboldi; F Santeusanio; C Porcellati; P Brunetti
Journal:  Hypertension       Date:  2000-12       Impact factor: 10.190

5.  Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study.

Authors:  Michiel J Bos; Peter J Koudstaal; Albert Hofman; Jacqueline C M Witteman; Monique M B Breteler
Journal:  Stroke       Date:  2006-05-04       Impact factor: 7.914

6.  Knockout of the urate oxidase gene provides a stable mouse model of hyperuricemia associated with metabolic disorders.

Authors:  Jie Lu; Xu Hou; Xuan Yuan; Lingling Cui; Zhen Liu; Xinde Li; Lidan Ma; Xiaoyu Cheng; Ying Xin; Can Wang; Keke Zhang; Xuefeng Wang; Wei Ren; Ruixia Sun; Zhaotong Jia; Zibin Tian; Qing-Sheng Mi; Changgui Li
Journal:  Kidney Int       Date:  2017-07-18       Impact factor: 10.612

7.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren
Journal:  Atherosclerosis       Date:  2016-09       Impact factor: 5.162

8.  Trends in serum uric acid levels 1961--1980.

Authors:  R J Glynn; E W Campion; J E Silbert
Journal:  Arthritis Rheum       Date:  1983-01

Review 9.  KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.

Authors:  Lesley A Inker; Brad C Astor; Chester H Fox; Tamara Isakova; James P Lash; Carmen A Peralta; Manjula Kurella Tamura; Harold I Feldman
Journal:  Am J Kidney Dis       Date:  2014-03-16       Impact factor: 8.860

10.  Added predictive value of high uric acid for cardiovascular events in the Ambulatory Blood Pressure International Study.

Authors:  Gianpaolo Reboldi; Paolo Verdecchia; Francesca Saladini; Marina Pane; Lawrence J Beilin; Kazuo Eguchi; Yutaka Imai; Kazuomi Kario; Takayoshi Ohkubo; Sante D Pierdomenico; Joseph E Schwartz; Lindon Wing; Paolo Palatini
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-06       Impact factor: 3.738

View more
  3 in total

1.  Which serum uric acid levels are associated with increased cardiovascular risk in the general adult population?

Authors:  Alena Krajčoviechová; Peter Wohlfahrt; Jan Bruthans; Pavel Šulc; Věra Lánská; Lenka Eremiášová; Jan Pudil; Aleš Linhart; Jan Filipovský; Otto Mayer; Jiří Widimský; Milan Blaha; Claudio Borghi; Renata Cífková
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-04-09       Impact factor: 3.738

Review 2.  Uric Acid and Hypertension: Prognostic Role and Guide for Treatment.

Authors:  Federica Piani; Arrigo F G Cicero; Claudio Borghi
Journal:  J Clin Med       Date:  2021-01-24       Impact factor: 4.241

3.  Association of Uric Acid With Blood Pressure in Hypertension Between Treatment Group and Non-treatment Group.

Authors:  Ning Ding; Yong Long; Changluo Li; Liudang He; Yingjie Su
Journal:  Front Cardiovasc Med       Date:  2022-01-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.